AD is now recognized as a multifactorial and heterogeneous disorder, with distinct pathological subtypes (ranging from amyloidogenic forms to variants dominated by tau pathology or altered brain network connectivity) that underscore the complex interplay between protein accumulation, metabolic dysfunction, and neuroinflammation [6,7]. The gene discussed is MAPT; the disease is Alzheimer disease.